FIZE Medical was proud to exhibit at the American Association for Thoracic Surgery (AATS) 2025 conference, joining leading clinicians and innovators focused on advancing cardiothoracic surgery and postoperative critical care.
Acute Kidney Injury (AKI) remains one of the most common and serious complications following cardiac surgery, with incidence rates as high as 30% (Mehta et al., Circulation). Early detection and timely intervention are key to improving outcomes, reducing ICU stays, and preventing long-term kidney damage.
Throughout the event, we heard a consistent theme from clinicians: the need for smarter, data-driven solutions to guide decision-making. FIZE Medical was proud to demonstrate how our FIZE kUO® real-time urine output monitoring platform addresses this challenge, offering continuous, minute-by-minute fluid data to support earlier recognition of AKI and more informed care.
